ICVI 2018 - Vaccine Conferences | World Vaccine Conferences | Vaccines Congress | Vaccine Conference 2018 | Immunology Conferences | 2019 | 2020 | Science Access Conferences | USA | Europe | Tokyo

Website http://vaccines.congressseries.com | Edit Freely

Category Vaccine Conferences,Vaccine Conference 2018,World Vaccine Conference,Vaccines Congress,Annual Vaccine Congress,Vaccines Congress 2018,Immunology Congress,Immunology Conference,Vaccine Summits 2018,Vaccine Conferences 2018,Immunology Conferences Tokyo,Immunization Congress 2018,World Vaccine Congress,Bcg Vaccines,Tdap Shot, Science Access Conferences,Immunization Conferences

Deadline: April 16, 2018 | Date: April 18, 2018-April 20, 2018

Venue/Country: Tokyo, Japan

Updated: 2017-09-18 15:20:38 (GMT+9)

Call For Papers - CFP

This logical gathering on Immunization will convey a chance to share potential advantages and constraints of antibodies in avoiding and control of infectious diseases and non-infectious diseases consequently improving the quality and longevity of life. Explore the ideas on Nanotechnology and Advances in Vaccine Technology. This session also discourses about the Pediatric Vaccination, vaccines in veterinary, plants and for pregnancy, Cancer Vaccines, Bacterial and Viral Vaccines.

Standard immunization currently averts an estimated two to three million deaths every year in all age group. Innovative technology solutions that help to ensure vaccine effectiveness, efficiency, safety, and storage are enabling immunization programs to save even more lives and the current conference focus on Cancer Immunology, Molecular Immunology, and Clinical Immunology. Without vaccines as well as safe vaccine distribution and delivery practices, deaths, particularly in children, would increase dramatically. The impact of vaccines goes far beyond saving lives and recovering the health of HIV-infected people and Hepatitis. Vaccination is in every sense an investment, with wider benefits that accrue across a lifetime. Enhancing financial security and reducing risk, eradicating infection through vaccination may lead to increased investment and improved political and economic stability and healthy people in the world.

Vaccine Conference 2018 brings all the top researchers, innovators and experts in the field with an opportunity to interact and discuss the latest technologies and challenges in Vaccinology. There is nothing more powerful than when this elite community comes together to share ideas, research matters, and hope.

And also the organizing committee is confident that participants will benefit from the high-value scientific program and welcome all the researchers and experts to join us for these 3 days of stimulating discussions, knowledge sharing.

Vaccine Conference 2018 conference organized at Tokyo. It is a most populous city and business hub of the Japan. Tokyo is a center of international trading and tourism and as the leading conference and exhibition venue in this part of the world.

Market Analysis of Vaccines:

The global vaccine market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8% from 2014 to 2019.

Key players in the Vaccine market

Astellas Pharma Inc. (Japan)

CSL Limited (Australia)

Emergent Bio Solutions, Inc. (U.S.)

GlaxoSmithKline, plc. (U.K.)

Johnson & Johnson (U.S.)

MedImmune, LLC (U.S.)

Merck & Co. (U.S.)

Pfizer, Inc. (U.S.)

Sanofi Pasteur (France)

Serum Institute of India Pvt. Ltd. (India)